Summary
Updated Aug 30, 2026
Maximo F. Nougues is Chief Financial Officer of PUMA BIOTECHNOLOGY, INC. (PBYI). 3 SEC Form 4 filings on record going back to 2025, most recently on 9 July 2026. Most recent open-market trade: sold $78K of PBYI on 9 July 2026. Lifetime open-market sales: $111K.
Recent Transactions
4Every recent SEC Form 4 transaction Maximo F. Nougues has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Maximo F. Nougues files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alan H. Auerbach - $364K of PBYI open-market activity in the last 12 months
- Adrian Senderowicz - $194K of PBYI open-market activity in the last 12 months
- Jay M. Moyes - $159K of PBYI open-market activity in the last 12 months
- Michael Patrick Miller - $97K of PBYI open-market activity in the last 12 months
- Allison Dorval - $84K of PBYI open-market activity in the last 12 months
- Troy Edward Wilson - $78K of PBYI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Maximo F. Nougues?
Maximo F. Nougues is a corporate insider, tracked as Chief Financial Officer of PUMA BIOTECHNOLOGY, INC. (PBYI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Maximo F. Nougues submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Maximo F. Nougues been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($111K) across all tracked filings.
Where can I see all of Maximo F. Nougues's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Maximo F. Nougues and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
